［1］Mogensen CE. Early diabetic renal involvement and nephropathy. In: Alberti KGMM. Krall Lp (eds). The Diabetes Annual(1/3). Amsterdan: Elsevier, 1987∶306-311.［2］WANG XB, SANG Y, KONG XM, et al. Clinical observation on treatment of non-insulin dependent type of diabetes mellitus accompanied with microalbuminuria by Tangshen capsule combining western medicine. CJIM(Chin) 1997;17(10)∶622-623.［3］LU RH. Diagnosis and treatment of diabetes mellitus and its complications by traditional Chinese and western medicine. Beijing: People's Health Publishing House, 1998∶527-531.［4］Febre J, Balant LP, Dayerpa, et al. The kidney in maturity on set diabetes mellitus: a clinical study on 510 patients. Kidney Int 1982;21∶730-738.［5］David M, Neumann L, Lishher M. Plasma lipids and the progression of nephropathy in diabetes mellitus type 2: effect of ACE inhibitors. Kidney Int 1995;47∶907.［6］CAO SF, FANG FZ, AN XY, et al. Significance of microalbuminuria, blood and urine β2-MG and THP in diagnosis of early stage diabetic nephropathy. Chinese J Nephrology 1992;8(3)∶164-165.
展开▼
机译：［1］ Mogensen CE。早期糖尿病肾脏受累和肾病。在：阿尔贝蒂KGMM。 Krall Lp（eds）。糖尿病年度（1/3）。阿姆斯特丹：爱思唯尔，1987：306-311。［2］王新兵，桑S，孔新民，等。唐神胶囊联合西药治疗非胰岛素依赖型糖尿病伴微量白蛋白尿的临床观察。 CJIM（Chin）1997; 17（10）∶622-623。［3］吕润华。中西医结合对糖尿病及其并发症的诊治。北京：人民卫生出版社，1998：527-531。［4］ Febre J，Balant LP，Dayerpa等。糖尿病患者肾脏成熟：510名患者的临床研究。 Kidney Int 1982; 21：730-738。［5］ David M，Neumann L，Lishher M. 2型糖尿病患者的血脂水平和肾病进展：ACE抑制剂的作用。肾脏国际，1995; 47：907。［6］曹顺福，方福Z，安玉霞，等。微量白蛋白尿，血液和尿液中的β2-MG和THP在诊断早期糖尿病肾病中的意义。中华肾脏病杂志1992; 8（3）1：164-165。
展开▼
